Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diagnosing osteoporosis: Laboratory tests].

Bernard Cortet1

  • 1Département universitaire de rhumatologie, EA 4032, CHU de Lille (59). bcortet@chru-lille.fr

Presse Medicale (Paris, France : 1983)
|October 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostin.

Diabetes & metabolism·2026
Same author

Health-related quality of life in French adults with X-linked hypophosphatemia: real-world data from the International XLH Registry.

JBMR plus·2026
Same author

The impact of DXA findings on general practitioners' decision regarding first-line oral bisphosphonates in postmenopausal osteoporosis-data from French General Practice (the IMOGENE study).

Archives of osteoporosis·2026
Same author

Bone Health Following Lifestyle-Induced Weight Loss in Individuals With Overweight/Obesity: A Narrative Review.

Obesity (Silver Spring, Md.)·2025
Same author

METHOFRACT, a methotrexate osteopathy multicentre cohort study.

RMD open·2025
Same author

Parathyroid hormone receptor agonists in the management of osteoporosis.

Nature reviews. Rheumatology·2025
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Beyond one-size-fits-all: Personalising health communication to drive real behaviour change.

Presse medicale (Paris, France : 1983)·2026
Same journal

Metacognition and post-decisional processing in clinical decision-making.

Presse medicale (Paris, France : 1983)·2026
Same journal

Fast-and-frugal decision trees for clinicians.

Presse medicale (Paris, France : 1983)·2026
Same journal

Toxic and explosive risks in pharmacy: an underestimated reality.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Investigate malignant or metabolic causes for low bone density. While osteoporosis shows normal calcium and phosphate, vitamin D deficiency is common and bone remodeling markers aid treatment decisions.

Area of Science:

  • Endocrinology
  • Metabolic Bone Disease
  • Geriatric Medicine

Context:

  • Low bone mineral density (BMD) necessitates investigation for underlying causes.
  • Fragility fractures or incidental low BMD findings warrant a thorough diagnostic workup.
  • Distinguishing osteoporosis from other metabolic bone diseases is crucial for effective management.

Purpose:

  • To outline the diagnostic approach for identifying secondary causes of low BMD.
  • To highlight the role of laboratory testing in evaluating bone metabolism.
  • To emphasize the importance of addressing vitamin D deficiency and utilizing bone remodeling markers.

Summary:

  • Malignant or metabolic etiologies must be excluded in patients with low BMD.
  • Standard osteoporosis evaluation reveals normal calcium and phosphate metabolism.

Related Experiment Videos

  • Vitamin D deficiency is prevalent and requires targeted supplementation; bone remodeling markers assist in complex treatment scenarios.

    • Impact:

    • Facilitates accurate diagnosis of secondary osteoporosis.
    • Guides appropriate laboratory test selection for bone density assessment.
    • Improves patient management by addressing specific deficiencies and informing therapeutic strategies.